LTLuísa Martins Trindade

Luísa Martins Trindade

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Luísa Martins Trindade has a total of 38 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Vitamin C and L-arginine as potential synergistic adjuvants to recover intestinal mucositis induced by chemotherapy

    by Amanda Dias Borges, Raquel Baumgratz Marques, Luiz Octávio Pires, Luísa Martins Trindade, Nayara Salgado Vieira Sette, Maria Emília Rabelo Andrade, Samanta Thomas-Valdés, Paola Caroline Lacerda Leocádio, Jacqueline Isaura Alvarez-Leite, Fernanda Rezende Souza, et al.

  • Limosilactobacillus reuteri UN41 improves the survival rate and exhibits hepatoprotective effects in a murine model of Salmonella infection

    by Melina A. Cordeiro, Vivian C. Miranda, Katharina O. Barros, Paulo H. F. Carmo, Luísa M. Trindade, Simone O. A. Fernandes, Valbert N. Cardoso, Rosa M. E. Arantes, Mayra F. Ricci, Silvia B. Moura, et al.

    Salmonellosis poses a significant public health threat, potentially leading to severe complications, ranging from enteritis to life-threatening septicemia. Salmonella enterica ssp. enterica serovar Typhimurium has the ability to translocate from the intestine to the liver via the hepatic portal system, causing severe lesions in the organ. The development of new treatment strategies is crucial, due to clinical burden of this infection. In this context, probiotics have emerged as a promising therapeutic avenue due to their multifaceted mechanisms of action. The aim of this study was to investigate the probiotic potential of two strains of Limosilactobacillus reuteri (UN34 and UN41) in a murine model of salmonellosis. Although both strains demonstrated in vitro characteristics indicative of potential probiotics, only the UN41 strain improved the survival rate of mice infected with S. Typhimurium, highlighting that the probiotic effect is strain-specific. In the in vivo model, administration of UN41 also attenuated neutrophilic infiltration, reduced bacterial translocation to the liver, lowered AST levels, and mitigated liver injury. These findings underscore the potential of L. reuteri UN41 as a promising probiotic candidate for mitigating the impact of salmonellosis.

  • Mitigation of chemotherapy-induced experimental intestinal mucositis through postbiotic lactate

    by Isabel David Matos, Amanda Dias Borges, Luísa Martins Trindade, Maria Emília Rabelo Andrade, Gregório Grama Cavalcante, Paola Caroline Lacerda Leocádio, Jacqueline Isaura Alvarez-Leite, Geovanni Dantas Cassali, Bruno Galotti Costa, Flaviano dos Santos Martins, et al.

    Postbiotic lactate modulates the immune system in inflammatory bowel diseases. However, its role in experimental intestinal mucositis (IM) has not been elucidated. This study aimed to evaluate the effects of lactate supplementation (1 and 2 × 10−1 mol/L) in a 5-fluorouracil (5-FU)-induced IM model. Male BALB/c mice (6–8 weeks old) were randomly divided into four groups: control (CTL), mucositis (MUC), mucositis with 1 × 10−1 mol/L lactate solution (MUC10), and mucositis with 2 × 10−1 mol/L lactate solution (MUC200). Lactate was administered via oral gavage for 10 days. Following the treatment period, the animals were subjected to an intraperitoneal injection of 300 mg/kg 5-FU to induce IM and were euthanized 72 h later for analysis. The MUC group presented intestinal damage with a poor histological score and decreased morphometric parameters as well as decreased mucus production and increased inflammatory infiltration and intestinal permeability compared to those of the CTL group (p < 0.05). However, the MUC200 group exhibited better results for the evaluated parameters than the MUC group (p < 0.05). Notably, the results in the MUC10 group were similar to those in the MUC group (p > 0.05). In conclusion, lactate supplementation attenuates mucositis-induced damage in a dose-dependent manner.


  • Open Access

    Association between KRAS mutation and alcohol consumption in Brazilian patients with colorectal cancer

    by Bianca Gomes-Fernandes, Luísa Martins Trindade, Marcela de Castro Bastos Rodrigues, João Pedro Duarte Cardoso, Frederico Temponi Lima, Luíza Rogerio, Simone de Vasconcelos Generoso, Juliana Garcia Carneiro, Rodrigo Gomes da Silva, Renan Pedra de Souza, et al.

    Colorectal cancer (CRC) is a leading cause of morbidity and mortality worldwide. Detection before metastasis and efficient treatment of disease significantly improve patient survival and quality of life. However, limitations in diagnosis and postoperative surveillance are associated with low CRC detection and survival rates. Thus, this project aimed to evaluate the molecular profile of patients diagnosed with CRC, as molecular biomarkers constitute a new frontier for diagnosis, treatment and prognosis. Methods and Results: 42 patients were included in the study, predominantly male (59.5%), with a median age of 63 years (SD: 10.0; min: 41; max: 83). The majority of primary tumors were located in the rectum (38.1%), in the sigmoid (33.3%) and in the ascending (21.4%) colon. We evaluated the genes KRAS, NRAS, BRAF, EGFR and TP53 using Sanger sequencing. Somatic and germline mutations were found in the KRAS, EGFR and TP53 genes, with the most common somatic alteration being rs121913529 in KRAS. This variant was also strongly associated with alcoholism (p = 0.002). Furthermore, patients with somatic mutations in TP53 had significantly higher mortality compared to those with wild-type alleles (OR: 11.2; 95% CI 1.25–2.45). Conclusions: Our findings support a relationship between alcohol consumption and the rs121913529 mutation, which is classified as pathogenic for colorectal cancer. Thus, further studies investigating the link between alcohol consumption, colorectal carcinogenesis and tumor progression ought to be conducted.